Our main goal was to assess whether the combination of tumor marker concentrations and expression levels of chosen miRNAs in tissues and exosomes is better than only using the CRC biochemical gold standards CEA and CA 19-9. The gene discussed is CEACAM5; the disease is neoplasm.